alexa Abstract | Review on the Anticancer and In-silico Binding Studies of Phenanthroindolizidine Alkaloids

Chemical Informatics
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article Open Access


Background: Cancer is the major cause of death throughout the world. In the developing world, the rate of death increases due to old age and changes in the lifestyle of people. At present, the researchers from multidisciplinary areas are focusing on strategies to combat this disease. Several chemotherapeutic, cytotoxic and immunomodulatory drugs are being explored from natural sources like plants, insects and marine organisms. Alkaloids belonging to the phenanthroindolizidine class are an example of such phytochemicals isolated from natural sources and found to exhibit interesting pharmacological properties. These alkaloids are well known for their cytotoxic activity, due to the inhibition of protein and nucleic acid synthesis. Hence numerous approaches to synthesize the phenanthroindolizidines and their analogues have been reported.

Method and findings: This review will hence provide an overview on the anti-cancer effects of Phenanthroindolizidine Alkaloids (PAs) reported from scientific and patent literature. The details of the mode of actions, study models, effective dosages, combination therapy and other pharmacological aspects of the alkaloid will be highlighted. Some of these alkaloids were found to possess anti-cancer activity by inhibiting the overexpression of COX-2 enzyme and NF-kB receptors, the deregulation of which is found to cause tumors. Further studies related to the in-silico docking studies confirm their interaction with COX-2 protein which is one of the important targets for treating inflammation based cancer.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Anita A Mandhare Sivakami A Dhulap Abhijeet S Dhulap Satish C Biradar


Phenanthroindolizidine alkaloids, Anticancer, COX-2 enzyme, In-Silico studies, Cytotoxic, Patents, Use of Chemical Structures, Molecular Graphics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version